ENTECAVIR

ENTECAVIR was reported 7876 times

ENTECAVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD HIV RNA DECREASED 22 0.6286
1 GENOTYPE DRUG RESISTANCE TEST 30 0.6250
2 ASYMPTOMATIC VIRAL HEPATITIS 4 0.5714
3 PAROTID GLAND HAEMORRHAGE 6 0.4615
4 ELECTROCARDIOGRAM P PULMONALE 3 0.3333
5 HEPATITIS B DNA INCREASED 129 0.2267
6 OPTIC DISC HYPERAEMIA 4 0.2000
7 HEPATITIS B E ANTIGEN POSITIVE 7 0.1707
8 ACQUIRED AMINOACIDURIA 5 0.1471
9 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 4 0.1429
10 HEPATITIS B ANTIGEN POSITIVE 5 0.1389
11 FEMORAL PULSE DECREASED 3 0.1364
12 BLOOD URIC ACID 3 0.1200
13 RENAL GLYCOSURIA 7 0.1148
14 HAEMORRHAGIC CHOLECYSTITIS 4 0.1111
15 MALIGNANT ANORECTAL NEOPLASM 5 0.0962
16 HYPOCALCIURIA 4 0.0952
17 HEPATITIS B DNA ASSAY POSITIVE 10 0.0952
18 CAROTID PULSE DECREASED 3 0.0938
19 ALKALOSIS HYPOKALAEMIC 3 0.0833
20 HEPATITIS B SURFACE ANTIGEN POSITIVE 19 0.0823
21 EXPOSURE VIA BODY FLUID 43 0.0704
22 SCHISTOSOMIASIS 4 0.0690
23 VIRAL UVEITIS 4 0.0678
24 HEPATITIS B REACTIVATION 127 0.0661
25 URINE PHOSPHORUS INCREASED 5 0.0633
26 PORTAL VEIN OCCLUSION 6 0.0583
27 HEPATITIS B 270 0.0573
28 HYPOPHOSPHATAEMIC OSTEOMALACIA 8 0.0552
29 VIRAL MUTATION IDENTIFIED 120 0.0522
30 HYPERPHOSPHATURIA 4 0.0519
31 VIRAL LOAD INCREASED 120 0.0517
32 HEPATIC NEOPLASM MALIGNANT 107 0.0505
33 HYPOURICAEMIA 11 0.0485
34 HEPATIC NEOPLASM MALIGNANT RECURRENT 5 0.0472
35 GENOTYPE DRUG RESISTANCE TEST POSITIVE 41 0.0471
36 HEPATECTOMY 8 0.0449
37 OSTEOMALACIA 59 0.0440
38 FANCONI SYNDROME ACQUIRED 58 0.0437
39 MULTIPLE-DRUG RESISTANCE 57 0.0400
40 RETINOPATHY HYPERTENSIVE 9 0.0393
41 HEPATIC CALCIFICATION 4 0.0388
42 AMINOACIDURIA 5 0.0388
43 FANCONI SYNDROME 36 0.0363
44 ACUTE HEPATITIS B 7 0.0340
45 HEPATOCELLULAR CARCINOMA 181 0.0329
46 VIRAL LOAD DECREASED 4 0.0323
47 GASTROENTERITIS STAPHYLOCOCCAL 4 0.0317
48 ALPHA 1 FOETOPROTEIN INCREASED 16 0.0306
49 PORTAL FIBROSIS 5 0.0303
50 THERAPEUTIC EMBOLISATION 8 0.0302
51 BETA 2 MICROGLOBULIN INCREASED 6 0.0300
52 SJS-TEN OVERLAP 5 0.0282
53 PLATELET DYSFUNCTION 5 0.0255
54 HEPATITIS B VIRUS TEST POSITIVE 7 0.0253
55 RETINAL DEPIGMENTATION 5 0.0234
56 RENAL TUBULAR INJURY 10 0.0234
57 BETA 2 MICROGLOBULIN URINE INCREASED 3 0.0229
58 DRUG RESISTANCE 356 0.0218
59 HYPOPHOSPHATAEMIA 103 0.0217
60 CHRONIC HEPATITIS B 4 0.0216
61 MYCOPLASMA INFECTION 8 0.0216
62 VASCULAR STENT STENOSIS 5 0.0209
63 BLOOD PHOSPHORUS DECREASED 48 0.0207
64 GASTRIC VARICES HAEMORRHAGE 5 0.0205
65 PATHOGEN RESISTANCE 111 0.0201
66 NEONATAL RESPIRATORY DISTRESS 9 0.0200
67 FOETAL HYPOKINESIA 10 0.0200
68 CRYOGLOBULINAEMIA 9 0.0191
69 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL 3 0.0186
70 TUMOUR ASSOCIATED FEVER 4 0.0178
71 CANCER SURGERY 10 0.0168
72 EPISCLERITIS 7 0.0158
73 SEROSITIS 5 0.0157
74 FOETAL HEART RATE ABNORMAL 11 0.0154
75 SYPHILIS 6 0.0153
76 NODULAR REGENERATIVE HYPERPLASIA 7 0.0145
77 BLOOD URIC ACID DECREASED 5 0.0144
78 ANTITHROMBIN III DECREASED 3 0.0142
79 VIRAEMIA 11 0.0139
80 TESTICULAR ATROPHY 8 0.0134
81 PORTAL VEIN THROMBOSIS 30 0.0130
82 RETINAL TOXICITY 9 0.0127
83 ALANINE AMINOTRANSFERASE DECREASED 6 0.0126
84 LIVER TRANSPLANT 34 0.0125
85 LIVER TRANSPLANT REJECTION 17 0.0120
86 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 11 0.0118
87 HEPATIC ENCEPHALOPATHY 82 0.0117
88 DISSEMINATED CRYPTOCOCCOSIS 4 0.0112
89 OESOPHAGEAL VARICES HAEMORRHAGE 18 0.0110
90 HEPATIC CIRRHOSIS 136 0.0109
91 RENAL TUBULAR DYSFUNCTION 4 0.0109
92 THREATENED LABOUR 4 0.0108
93 COMA HEPATIC 7 0.0107
94 PREGNANCY ON CONTRACEPTIVE 13 0.0106
95 ILEAL ULCER 6 0.0105
96 RENAL TUBULAR ACIDOSIS 15 0.0104
97 PNEUMONIA INFLUENZAL 7 0.0103
98 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 3 0.0098
99 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19 0.0095
100 HEPATORENAL SYNDROME 12 0.0089
101 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 6 0.0087
102 ASPARTATE AMINOTRANSFERASE DECREASED 3 0.0085
103 GLYCOSURIA 9 0.0084
104 HEPATIC FAILURE 193 0.0084
105 ENCEPHALITIS HERPES 3 0.0084
106 MALARIA 5 0.0083
107 HEPATIC NEOPLASM 20 0.0082
108 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0082
109 HEPATITIS E 8 0.0081
110 BLOOD HIV RNA INCREASED 8 0.0080
111 HEPATIC FIBROSIS 19 0.0080
112 PROTEIN URINE 5 0.0077
113 VIROLOGIC FAILURE 26 0.0077
114 ABORTION INDUCED 58 0.0076
115 GRANULOMATOSIS WITH POLYANGIITIS 5 0.0075
116 CREATININE RENAL CLEARANCE INCREASED 4 0.0072
117 ARACHNOIDITIS 4 0.0070
118 HEPATITIS VIRAL 4 0.0068
119 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0068
120 HYDROTHORAX 4 0.0067
121 HEPATIC CANCER METASTATIC 4 0.0067
122 SPLENECTOMY 6 0.0067
123 RETICULOCYTE COUNT INCREASED 4 0.0066
124 VARICES OESOPHAGEAL 14 0.0065
125 LIVER ABSCESS 14 0.0064
126 EXPOSURE VIA FATHER 8 0.0064
127 HEPATIC CANCER 103 0.0064
128 PACKED RED BLOOD CELL TRANSFUSION 8 0.0063
129 ELECTROCARDIOGRAM CHANGE 5 0.0063
130 SUSPECTED COUNTERFEIT PRODUCT 14 0.0062
131 RENAL TUBULAR DISORDER 14 0.0061
132 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 7 0.0061
133 RENAL TRANSPLANT 15 0.0060
134 FIXED ERUPTION 5 0.0060
135 BLOOD FIBRINOGEN DECREASED 4 0.0059
136 ABDOMINAL LYMPHADENOPATHY 3 0.0059
137 CELL DEATH 8 0.0059
138 GLUCOSE URINE PRESENT 5 0.0058
139 POSTPARTUM HAEMORRHAGE 5 0.0058
140 PYELONEPHRITIS ACUTE 8 0.0058
141 GASTROINTESTINAL TUBE INSERTION 10 0.0058
142 PROTEIN URINE PRESENT 20 0.0058
143 BONE MARROW OEDEMA 4 0.0057
144 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0056
145 PLATELET TRANSFUSION 4 0.0056
146 PYLORIC STENOSIS 4 0.0056
147 CHRONIC GASTRITIS 7 0.0056
148 ASCITES 116 0.0055
149 BLOOD BILIRUBIN UNCONJUGATED INCREASED 3 0.0054
150 HEPATITIS FULMINANT 12 0.0053
151 CREATININE RENAL CLEARANCE DECREASED 16 0.0052
152 GENE MUTATION 6 0.0052
153 GLOMERULONEPHRITIS MEMBRANOUS 4 0.0051
154 SEBORRHOEIC DERMATITIS 5 0.0050
155 BILIRUBIN CONJUGATED INCREASED 9 0.0050
156 HERPES OPHTHALMIC 4 0.0050
157 VENOOCCLUSIVE LIVER DISEASE 16 0.0049
158 ACQUIRED GENE MUTATION 4 0.0049
159 GLOMERULONEPHRITIS 8 0.0049
160 HEPATIC FUNCTION ABNORMAL 118 0.0049
161 HYPOPROTEINAEMIA 6 0.0049
162 ABORTION MISSED 5 0.0048
163 LUNG ADENOCARCINOMA 10 0.0048
164 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0048
165 BLOOD UREA ABNORMAL 3 0.0048
166 BLOOD LACTIC ACID INCREASED 16 0.0047
167 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 6 0.0047
168 OTOTOXICITY 6 0.0047
169 BLOOD AMYLASE INCREASED 8 0.0047
170 PSYCHOMOTOR RETARDATION 9 0.0046
171 BILE DUCT STENOSIS 4 0.0046
172 LIPASE INCREASED 26 0.0045
173 FRACTURED SACRUM 4 0.0045
174 AMYLASE INCREASED 11 0.0045
175 BREAST FEEDING 3 0.0044
176 ACUTE HEPATIC FAILURE 39 0.0043
177 HYPOALBUMINAEMIA 22 0.0043
178 METABOLIC ENCEPHALOPATHY 9 0.0042
179 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0042
180 OCULAR ICTERUS 14 0.0042
181 RHEUMATIC DISORDER 5 0.0040
182 NOSOCOMIAL INFECTION 7 0.0040
183 PNEUMONIA PNEUMOCOCCAL 4 0.0039
184 HEPATIC PAIN 12 0.0039
185 BLOOD URIC ACID INCREASED 15 0.0039
186 OESOPHAGEAL HAEMORRHAGE 4 0.0039
187 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0038
188 NORMAL NEWBORN 15 0.0038
189 BLOOD BILIRUBIN INCREASED 79 0.0038
190 BLOOD CREATINE PHOSPHOKINASE INCREASED 86 0.0037
191 BK VIRUS INFECTION 7 0.0037
192 CARDIAC FAILURE ACUTE 15 0.0036
193 HYPERAMMONAEMIA 12 0.0035
194 ABORTION 8 0.0035
195 MYOGLOBIN BLOOD INCREASED 4 0.0035
196 CHOLANGIOCARCINOMA 3 0.0034
197 NEPHROPATHY TOXIC 24 0.0034
198 INFERTILITY 4 0.0034
199 STEM CELL TRANSPLANT 6 0.0034
200 ALANINE AMINOTRANSFERASE INCREASED 156 0.0034
201 CRYPTOCOCCOSIS 3 0.0033
202 DRUG TOLERANCE 12 0.0033
203 BLOOD CHLORIDE INCREASED 4 0.0033
204 SOFT TISSUE INFECTION 4 0.0033
205 LYMPHOCYTOSIS 5 0.0033
206 AMYLOIDOSIS 4 0.0033
207 INTERVERTEBRAL DISCITIS 4 0.0032
208 PROTEINURIA 39 0.0032
209 METASTASES TO PERITONEUM 5 0.0032
210 RECTAL CANCER 7 0.0032
211 INTRA-ABDOMINAL HAEMORRHAGE 6 0.0032
212 NEPHRITIS 7 0.0032
213 TRANSPLANT DYSFUNCTION 4 0.0032
214 HYPERPARATHYROIDISM 5 0.0032
215 GLOMERULAR FILTRATION RATE DECREASED 22 0.0032
216 RENAL IMPAIRMENT 175 0.0032
217 JAUNDICE 68 0.0031
218 BLOOD ALKALINE PHOSPHATASE INCREASED 62 0.0031
219 HYPERURICAEMIA 9 0.0031
220 YELLOW SKIN 11 0.0031
221 TRANSAMINASES INCREASED 50 0.0031
222 LACTIC ACIDOSIS 62 0.0030
223 THYROIDITIS 5 0.0029
224 METASTASES TO LUNG 21 0.0028
225 HYPERBILIRUBINAEMIA 20 0.0028
226 HIV INFECTION 6 0.0028
227 LIVE BIRTH 12 0.0027
228 BILIARY DILATATION 3 0.0027
229 VIRAL INFECTION 60 0.0027
230 SPLENOMEGALY 23 0.0027
231 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 43 0.0027
232 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
233 HYPERTHERMIA 15 0.0027
234 LIVER DISORDER 80 0.0026
235 NEUTROPHIL COUNT DECREASED 65 0.0026
236 BILE DUCT OBSTRUCTION 5 0.0026
237 TUMOUR LYSIS SYNDROME 14 0.0026
238 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0026
239 BLOOD CREATINE INCREASED 8 0.0026
240 CANCER PAIN 4 0.0026
241 BENIGN PROSTATIC HYPERPLASIA 10 0.0026
242 CYTOMEGALOVIRUS VIRAEMIA 6 0.0026
243 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0025
244 PREMATURE RUPTURE OF MEMBRANES 5 0.0025
245 NEPHROTIC SYNDROME 12 0.0025
246 COMPRESSION FRACTURE 8 0.0025
247 APLASTIC ANAEMIA 9 0.0025
248 MATERNAL EXPOSURE DURING PREGNANCY 118 0.0025
249 HAEMOLYTIC ANAEMIA 17 0.0025
250 STATUS EPILEPTICUS 20 0.0025
251 CHOLESTASIS 32 0.0024
252 COVID-19 PNEUMONIA 9 0.0024
253 PULMONARY TUBERCULOSIS 8 0.0024
254 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0024
255 ABDOMINAL INFECTION 4 0.0024
256 HEPATITIS 44 0.0024
257 BLOOD CREATININE INCREASED 116 0.0024
258 CYTOKINE RELEASE SYNDROME 11 0.0024
259 MYOPATHY 15 0.0024
260 ADENOCARCINOMA OF COLON 3 0.0024
261 BLOOD CREATININE DECREASED 5 0.0024
262 BLOOD ALBUMIN DECREASED 14 0.0024
263 OSTEOPOROSIS 69 0.0023
264 CYTOPENIA 12 0.0023
265 MULTIPLE ORGAN DYSFUNCTION SYNDROME 35 0.0023
266 BLOOD CHOLESTEROL DECREASED 3 0.0023
267 GESTATIONAL DIABETES 8 0.0023
268 HEPATITIS ACUTE 11 0.0023
269 CAPILLARY LEAK SYNDROME 3 0.0023
270 PNEUMATOSIS INTESTINALIS 4 0.0023
271 ENTERITIS INFECTIOUS 3 0.0023
272 PORTAL HYPERTENSION 5 0.0023
273 B-CELL LYMPHOMA 6 0.0023
274 CHRONIC LYMPHOCYTIC LEUKAEMIA 7 0.0022
275 EARLY SATIETY 3 0.0022
276 LYMPHOMA 23 0.0021
277 DUODENAL ULCER HAEMORRHAGE 5 0.0021
278 PLATELET COUNT DECREASED 151 0.0021
279 LISTLESS 5 0.0021
280 ENTEROCOLITIS 7 0.0021
281 HELICOBACTER INFECTION 8 0.0021
282 ECTOPIC PREGNANCY 5 0.0021
283 LYMPHOCYTE COUNT DECREASED 25 0.0021
284 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0020
285 DIFFUSE LARGE B-CELL LYMPHOMA 8 0.0020
286 LIVER INJURY 24 0.0020
287 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0020
288 APLASIA PURE RED CELL 5 0.0020
289 LARYNGEAL OEDEMA 9 0.0020
290 HEPATOCELLULAR INJURY 24 0.0020
291 INTERSTITIAL LUNG DISEASE 62 0.0019
292 VASCULITIS 15 0.0019
293 FEMORAL NECK FRACTURE 7 0.0019
294 MYELOSUPPRESSION 8 0.0019
295 ENCEPHALOPATHY 32 0.0019
296 FEBRILE NEUTROPENIA 80 0.0019
297 STUPOR 5 0.0019
298 BLOOD BICARBONATE DECREASED 3 0.0019
299 ANURIA 13 0.0019
300 ERYTHEMA MULTIFORME 13 0.0019
301 THROMBOTIC MICROANGIOPATHY 11 0.0019
302 LYMPHOCYTE COUNT INCREASED 4 0.0019
303 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0018
304 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0018
305 ILEUS 16 0.0018
306 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0018
307 CYTOMEGALOVIRUS INFECTION 21 0.0018
308 DIABETES INSIPIDUS 3 0.0018
309 ADENOCARCINOMA 3 0.0018
310 GASTRIC HAEMORRHAGE 17 0.0018
311 METABOLIC ACIDOSIS 38 0.0018
312 EOSINOPHIL COUNT INCREASED 10 0.0018
313 DEPRESSIVE SYMPTOM 4 0.0018
314 HYPOKALAEMIA 57 0.0018
315 HEPATIC ENZYME ABNORMAL 6 0.0018
316 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0018
317 BLOOD CREATININE ABNORMAL 4 0.0018
318 HEPATITIS C 19 0.0018
319 FIBROSIS 4 0.0018
320 VENTRICULAR FIBRILLATION 15 0.0017
321 CHOLECYSTITIS 15 0.0017
322 PANCREATITIS ACUTE 27 0.0017
323 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0017
324 HEPATIC LESION 5 0.0017
325 TRANSFUSION 13 0.0017
326 HYPERPYREXIA 4 0.0017
327 ASPERGILLUS INFECTION 6 0.0017
328 LEUKOPENIA 59 0.0017
329 BLOOD UREA INCREASED 23 0.0017
330 PLEURISY 8 0.0017
331 HEPATOMEGALY 13 0.0017
332 BLOOD PHOSPHORUS INCREASED 3 0.0017
333 LIP OEDEMA 5 0.0017
334 SEPTIC SHOCK 48 0.0017
335 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
336 CAESAREAN SECTION 16 0.0017
337 COMPUTERISED TOMOGRAM ABNORMAL 3 0.0016
338 CHROMATURIA 28 0.0016
339 LUMBAR VERTEBRAL FRACTURE 5 0.0016
340 BREATH ODOUR 3 0.0016
341 CHOLECYSTITIS ACUTE 7 0.0016
342 TRANSPLANT REJECTION 9 0.0016
343 AGRANULOCYTOSIS 19 0.0016
344 BRONCHIOLITIS 4 0.0016
345 HYPERSENSITIVITY VASCULITIS 4 0.0016
346 MALABSORPTION 6 0.0016
347 SERUM FERRITIN INCREASED 6 0.0016
348 OTITIS MEDIA 4 0.0016
349 PEMPHIGOID 7 0.0016
350 WHITE BLOOD CELL COUNT DECREASED 113 0.0016
351 ACIDOSIS 9 0.0016
352 HYPERKALAEMIA 39 0.0016
353 HYPOGAMMAGLOBULINAEMIA 5 0.0016
354 CHOLANGITIS 6 0.0015
355 DERMATITIS EXFOLIATIVE 7 0.0015
356 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0015
357 AUTOIMMUNE HEPATITIS 7 0.0015
358 DRUG-INDUCED LIVER INJURY 24 0.0015
359 CYTOLYTIC HEPATITIS 5 0.0015
360 BONE MARROW FAILURE 27 0.0015
361 HYPERCALCAEMIA 13 0.0015
362 AMMONIA INCREASED 6 0.0015
363 JAUNDICE CHOLESTATIC 4 0.0015
364 OESOPHAGEAL CANDIDIASIS 4 0.0015
365 RENAL CYST 9 0.0015
366 RHABDOMYOLYSIS 45 0.0015
367 PRODUCT DOSE OMISSION IN ERROR 4 0.0015
368 PROTEIN TOTAL DECREASED 4 0.0014
369 MULTIPLE FRACTURES 17 0.0014
370 ESCHERICHIA SEPSIS 3 0.0014
371 THROMBOCYTOPENIA 108 0.0014
372 AZOTAEMIA 4 0.0014
373 PERICARDIAL EFFUSION 22 0.0014
374 BONE PAIN 59 0.0014
375 ENDOCARDITIS 5 0.0014
376 PERICARDITIS 10 0.0014
377 ANEURYSM 5 0.0014
378 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0014
379 ORGANISING PNEUMONIA 4 0.0014
380 INGUINAL HERNIA 6 0.0013
381 COLON CANCER 14 0.0013
382 RENAL CELL CARCINOMA 5 0.0013
383 BACTERAEMIA 10 0.0013
384 VITAMIN D DEFICIENCY 9 0.0013
385 SQUAMOUS CELL CARCINOMA 9 0.0013
386 C-REACTIVE PROTEIN INCREASED 31 0.0013
387 CONGESTIVE CARDIOMYOPATHY 5 0.0013
388 ABORTION SPONTANEOUS 40 0.0013
389 HYPOCALCAEMIA 17 0.0013
390 HEPATIC STEATOSIS 17 0.0013
391 BACTERIAL SEPSIS 3 0.0013
392 GRAFT VERSUS HOST DISEASE 7 0.0013
393 ALTERED STATE OF CONSCIOUSNESS 18 0.0013
394 MULTI-ORGAN FAILURE 22 0.0013
395 MELAENA 21 0.0013
396 STILLBIRTH 5 0.0013
397 LIGAMENT RUPTURE 4 0.0013
398 SEPSIS 100 0.0013
399 RENAL FAILURE 134 0.0012
400 LIVER FUNCTION TEST ABNORMAL 31 0.0012
401 HYPERTONIA 6 0.0012
402 ADRENAL INSUFFICIENCY 8 0.0012
403 ANXIETY DISORDER 3 0.0012
404 DERMATITIS ACNEIFORM 5 0.0012
405 PERITONITIS BACTERIAL 10 0.0012
406 ENTEROCOCCAL INFECTION 4 0.0012
407 HICCUPS 7 0.0012
408 SINUS TACHYCARDIA 13 0.0012
409 OSTEOPENIA 13 0.0012
410 FRACTURE 17 0.0012
411 SOPOR 13 0.0012
412 LUNG INFECTION 19 0.0012
413 IRON DEFICIENCY ANAEMIA 8 0.0012
414 BLOOD CALCIUM DECREASED 10 0.0012
415 RENAL INJURY 32 0.0012
416 BONE LESION 3 0.0012
417 NEUTROPENIA 95 0.0012
418 GENERALISED OEDEMA 10 0.0012
419 SPINAL PAIN 9 0.0012
420 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0012
421 HEPATIC ENZYME INCREASED 51 0.0012
422 ACUTE KIDNEY INJURY 114 0.0012
423 CARDIAC TAMPONADE 4 0.0012
424 HEPATITIS CHOLESTATIC 5 0.0012
425 APPENDICITIS 7 0.0012
426 HAEMATEMESIS 22 0.0011
427 PROTHROMBIN TIME PROLONGED 6 0.0011
428 DUODENAL ULCER 6 0.0011
429 RENAL TUBULAR NECROSIS 8 0.0011
430 RENAL DISORDER 37 0.0011
431 HUMERUS FRACTURE 4 0.0011
432 FACIAL PARALYSIS 6 0.0011
433 EYELID OEDEMA 11 0.0011
434 PSEUDOMONAS INFECTION 6 0.0011
435 LYMPHOPENIA 10 0.0011
436 NEOPLASM 8 0.0011
437 GINGIVAL BLEEDING 10 0.0011
438 CEREBRAL HAEMORRHAGE 29 0.0011
439 POLYNEUROPATHY 8 0.0011
440 GASTRITIS EROSIVE 4 0.0011
441 VENTRICULAR TACHYCARDIA 13 0.0011
442 CACHEXIA 4 0.0011
443 TREATMENT NONCOMPLIANCE 36 0.0011
444 PLASMA CELL MYELOMA 27 0.0011
445 VARICOSE VEIN 4 0.0011
446 PREGNANCY 18 0.0011
447 NEOPLASM MALIGNANT 46 0.0010
448 HAEMORRHOIDAL HAEMORRHAGE 4 0.0010
449 CARDIAC FAILURE 59 0.0010
450 GASTROENTERITIS 11 0.0010
451 STAPHYLOCOCCAL SEPSIS 4 0.0010
452 DISEASE RECURRENCE 17 0.0010
453 PERIPHERAL SENSORY NEUROPATHY 4 0.0010
454 GASTRIC ULCER 15 0.0010
455 MYOSITIS 6 0.0010
456 PNEUMONIA BACTERIAL 5 0.0010
457 URINE OUTPUT DECREASED 7 0.0010
458 INTENTIONAL DOSE OMISSION 7 0.0010
459 TYPE 1 DIABETES MELLITUS 4 0.0010
460 PREMATURE DELIVERY 11 0.0010
461 METASTASES TO BONE 10 0.0010
462 HAEMODIALYSIS 8 0.0010
463 GINGIVITIS 4 0.0010
464 HYPERTRIGLYCERIDAEMIA 4 0.0010
465 DEVICE RELATED INFECTION 12 0.0010
466 LARGE INTESTINE POLYP 5 0.0010
467 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0010
468 CEREBRAL INFARCTION 18 0.0010
469 ANHEDONIA 20 0.0010
470 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0010
471 RIB FRACTURE 14 0.0010
472 WHITE BLOOD CELL COUNT INCREASED 28 0.0010
473 HYPOXIA 23 0.0010
474 THERAPY INTERRUPTED 11 0.0010
475 BONE DENSITY DECREASED 23 0.0010
476 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0010
477 EPILEPSY 19 0.0009
478 TREATMENT FAILURE 48 0.0009
479 RETINAL HAEMORRHAGE 5 0.0009
480 HYDRONEPHROSIS 5 0.0009
481 DISEASE COMPLICATION 3 0.0009
482 DRUG ERUPTION 11 0.0009
483 HAEMATOTOXICITY 5 0.0009
484 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0009
485 HYPERLIPIDAEMIA 9 0.0009
486 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0009
487 NEUTROPHIL COUNT INCREASED 7 0.0009
488 RENAL FAILURE ACUTE 39 0.0009
489 PLEURAL EFFUSION 41 0.0009
490 SHOCK HAEMORRHAGIC 5 0.0009
491 ACUTE CORONARY SYNDROME 6 0.0009
492 CHRONIC MYELOID LEUKAEMIA 3 0.0009
493 CARDIAC PACEMAKER INSERTION 4 0.0009
494 TUBERCULOSIS 8 0.0009
495 FLANK PAIN 6 0.0009
496 HYPERGLYCAEMIA 24 0.0009
497 ATRIOVENTRICULAR BLOCK 5 0.0009
498 FOETAL EXPOSURE DURING PREGNANCY 49 0.0009
499 ONYCHOCLASIS 4 0.0009
500 DERMATITIS ALLERGIC 7 0.0009
501 CARDIOGENIC SHOCK 8 0.0009
502 HERPES SIMPLEX 4 0.0009
503 ANGINA UNSTABLE 5 0.0009
504 DYSLIPIDAEMIA 3 0.0009
505 EYELID PTOSIS 6 0.0009
506 COAGULOPATHY 11 0.0009
507 ANAEMIA 119 0.0009
508 PANCYTOPENIA 33 0.0009
509 DEMENTIA 15 0.0009
510 MENTAL STATUS CHANGES 18 0.0009
511 TUBULOINTERSTITIAL NEPHRITIS 11 0.0008
512 OLIGURIA 4 0.0008
513 DECREASED APPETITE 129 0.0008
514 PYREXIA 206 0.0008
515 MYOCARDITIS 5 0.0008
516 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0008
517 PNEUMONITIS 14 0.0008
518 HEPATOTOXICITY 12 0.0008
519 GASTRITIS 16 0.0008
520 TOXIC SKIN ERUPTION 6 0.0008
521 MALIGNANT NEOPLASM PROGRESSION 52 0.0008
522 PULMONARY MASS 8 0.0008
523 HAEMATOCRIT DECREASED 13 0.0008
524 HOSPITALISATION 72 0.0008
525 FOETAL DEATH 3 0.0008
526 ATRIAL FLUTTER 5 0.0008
527 GRANULOCYTOPENIA 4 0.0008
528 LYMPHADENOPATHY 20 0.0008
529 DEVICE OCCLUSION 5 0.0008
530 SUDDEN DEATH 7 0.0008
531 MALNUTRITION 6 0.0008
532 RASH MACULO-PAPULAR 12 0.0008
533 DRUG LEVEL INCREASED 9 0.0008
534 DYSPHAGIA 52 0.0008
535 TENDERNESS 6 0.0008
536 BLOOD POTASSIUM DECREASED 17 0.0008
537 TASTE DISORDER 5 0.0008
538 CHRONIC KIDNEY DISEASE 49 0.0008
539 DEAFNESS 14 0.0008
540 PANCREATITIS 31 0.0008
541 PROCEDURAL COMPLICATION 5 0.0008
542 ELECTROLYTE IMBALANCE 6 0.0008
543 DERMATITIS BULLOUS 4 0.0008
544 SPINAL COMPRESSION FRACTURE 5 0.0008
545 HAEMOPTYSIS 16 0.0008
546 SURGERY 26 0.0008
547 INCORRECT PRODUCT STORAGE 10 0.0008
548 SKIN FISSURES 7 0.0008
549 LOW BIRTH WEIGHT BABY 4 0.0008
550 ENTERITIS 3 0.0008
551 SHOCK 12 0.0008
552 REBOUND EFFECT 4 0.0008
553 OESOPHAGITIS 6 0.0007
554 COVID-19 25 0.0007
555 MYELODYSPLASTIC SYNDROME 8 0.0007
556 CHEILITIS 3 0.0007
557 PURPURA 5 0.0007
558 PNEUMOTHORAX 8 0.0007
559 DIABETIC NEUROPATHY 3 0.0007
560 RESPIRATORY FAILURE 40 0.0007
561 HYPONATRAEMIA 30 0.0007
562 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0007
563 CHOLELITHIASIS 18 0.0007
564 RED BLOOD CELL COUNT DECREASED 14 0.0007
565 HYPERTHYROIDISM 7 0.0007
566 FOOT FRACTURE 10 0.0007
567 MUSCLE ATROPHY 6 0.0007
568 DIALYSIS 8 0.0007
569 HAEMATURIA 19 0.0007
570 THERAPEUTIC RESPONSE DECREASED 29 0.0007
571 FACE OEDEMA 9 0.0007
572 CEREBRAL ISCHAEMIA 3 0.0007
573 ECONOMIC PROBLEM 10 0.0007
574 VISUAL FIELD DEFECT 4 0.0007
575 SKIN INFECTION 5 0.0007
576 INFECTION 64 0.0007
577 NEPHROPATHY 5 0.0007
578 HERPES ZOSTER 28 0.0007
579 ABDOMINAL DISTENSION 50 0.0007
580 HAEMOLYSIS 4 0.0007
581 ACUTE PULMONARY OEDEMA 3 0.0007
582 JOINT DISLOCATION 5 0.0007
583 PNEUMONIA ASPIRATION 12 0.0007
584 DELIRIUM 16 0.0007
585 STEVENS-JOHNSON SYNDROME 12 0.0007
586 PERITONITIS 11 0.0007
587 ELECTROCARDIOGRAM QT PROLONGED 17 0.0007
588 HYPERCHOLESTEROLAEMIA 4 0.0007
589 CARDIAC VALVE DISEASE 3 0.0007
590 UTERINE CANCER 4 0.0007
591 SUBARACHNOID HAEMORRHAGE 5 0.0007
592 PYELONEPHRITIS 4 0.0007
593 DEATH 387 0.0007
594 ERECTILE DYSFUNCTION 12 0.0007
595 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0007
596 PRODUCT USE IN UNAPPROVED INDICATION 79 0.0007
597 NEPHROLITHIASIS 20 0.0007
598 DRUG INTERACTION 77 0.0007
599 ATELECTASIS 5 0.0007
600 LOWER LIMB FRACTURE 8 0.0007
601 LUNG INFILTRATION 5 0.0007
602 ANGINA PECTORIS 15 0.0007
603 PETECHIAE 5 0.0007
604 ACUTE RESPIRATORY FAILURE 8 0.0007
605 FEEDING DISORDER 7 0.0007
606 NO THERAPEUTIC RESPONSE 8 0.0007
607 PHARYNGITIS 6 0.0007
608 PULMONARY HAEMORRHAGE 4 0.0007
609 DECUBITUS ULCER 4 0.0007
610 DIABETES MELLITUS 37 0.0006
611 HAEMATOCHEZIA 22 0.0006
612 EMBOLISM 4 0.0006
613 OEDEMA 24 0.0006
614 ABDOMINAL PAIN UPPER 90 0.0006
615 NEUROPATHY PERIPHERAL 38 0.0006
616 PNEUMONIA 139 0.0006
617 LEUKAEMIA 4 0.0006
618 TENDON RUPTURE 6 0.0006
619 MYALGIA 76 0.0006
620 COLITIS ISCHAEMIC 3 0.0006
621 STOMATITIS 24 0.0006
622 TEMPERATURE INTOLERANCE 4 0.0006
623 BLOOD GLUCOSE FLUCTUATION 5 0.0006
624 BLINDNESS UNILATERAL 6 0.0006
625 BLOOD TEST ABNORMAL 5 0.0006
626 LABORATORY TEST ABNORMAL 12 0.0006
627 ADVERSE EVENT 39 0.0006
628 DRUG DOSE OMISSION 98 0.0006
629 ISCHAEMIC STROKE 8 0.0006
630 CANDIDA INFECTION 6 0.0006
631 HAEMOGLOBIN DECREASED 44 0.0006
632 GENERAL PHYSICAL HEALTH DETERIORATION 41 0.0006
633 RASH PRURITIC 21 0.0006
634 HYPOPHAGIA 10 0.0006
635 PULMONARY FIBROSIS 7 0.0006
636 TYPE 2 DIABETES MELLITUS 14 0.0006
637 ESCHERICHIA INFECTION 3 0.0006
638 ABNORMAL FAECES 3 0.0006
639 SUPRAVENTRICULAR TACHYCARDIA 4 0.0006
640 BASAL CELL CARCINOMA 6 0.0006
641 MUSCULOSKELETAL CHEST PAIN 6 0.0005
642 INTERVERTEBRAL DISC DEGENERATION 4 0.0005
643 CHILLS 45 0.0005
644 TOOTH DISORDER 9 0.0005
645 THERAPY NON-RESPONDER 12 0.0005
646 PREMATURE BABY 12 0.0005
647 HYPOTHYROIDISM 11 0.0005
648 MUSCULAR WEAKNESS 44 0.0005
649 INTENTIONAL PRODUCT USE ISSUE 25 0.0005
650 ASPIRATION 4 0.0005
651 DERMATITIS 7 0.0005
652 HYPOACUSIS 14 0.0005
653 MYDRIASIS 5 0.0005
654 GASTROINTESTINAL HAEMORRHAGE 37 0.0005
655 BONE LOSS 6 0.0005
656 BLOOD MAGNESIUM DECREASED 3 0.0005
657 SKIN DISORDER 11 0.0005
658 ASTHENIA 139 0.0005
659 ACCIDENTAL OVERDOSE 13 0.0005
660 BLOOD SODIUM DECREASED 7 0.0005
661 FEMUR FRACTURE 13 0.0005
662 FUNGAL INFECTION 12 0.0005
663 DIARRHOEA 220 0.0005
664 OFF LABEL USE 222 0.0005
665 ATRIAL FIBRILLATION 35 0.0005
666 LUNG NEOPLASM MALIGNANT 15 0.0005
667 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0005
668 ABDOMINAL PAIN 82 0.0005
669 PERIPHERAL COLDNESS 5 0.0005
670 ARRHYTHMIA 18 0.0005
671 NEOPLASM PROGRESSION 11 0.0005
672 GALLBLADDER DISORDER 7 0.0005
673 POOR QUALITY SLEEP 7 0.0005
674 HYPERTENSIVE CRISIS 4 0.0005
675 HAEMORRHOIDS 7 0.0005
676 BACK PAIN 80 0.0005
677 THYROID CANCER 4 0.0005
678 DISEASE PROGRESSION 34 0.0005
679 DYSURIA 13 0.0005
680 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0005
681 TOXIC EPIDERMAL NECROLYSIS 5 0.0005
682 INTENTIONAL SELF-INJURY 7 0.0005
683 ACUTE MYELOID LEUKAEMIA 5 0.0005
684 HYPOKINESIA 5 0.0005
685 DRUG SCREEN POSITIVE 3 0.0005
686 EATING DISORDER 7 0.0005
687 SMALL INTESTINAL OBSTRUCTION 4 0.0005
688 WEIGHT DECREASED 89 0.0005
689 END STAGE RENAL DISEASE 7 0.0005
690 FATIGUE 237 0.0005
691 NODULE 4 0.0005
692 INFUSION RELATED REACTION 17 0.0005
693 EPISTAXIS 25 0.0005
694 LUNG DISORDER 15 0.0005
695 CARDIO-RESPIRATORY ARREST 15 0.0005
696 MENTAL IMPAIRMENT 8 0.0004
697 ANKLE FRACTURE 5 0.0004
698 SUBDURAL HAEMATOMA 5 0.0004
699 BODY HEIGHT DECREASED 4 0.0004
700 CATARACT 17 0.0004
701 CONDITION AGGRAVATED 77 0.0004
702 SKIN LESION 8 0.0004
703 POLLAKIURIA 13 0.0004
704 NO ADVERSE EVENT 41 0.0004
705 DEHYDRATION 43 0.0004
706 PRODUCT STORAGE ERROR 12 0.0004
707 FAECES DISCOLOURED 7 0.0004
708 RESPIRATORY DISTRESS 9 0.0004
709 BLISTER 16 0.0004
710 GASTRIC CANCER 7 0.0004
711 COLITIS 10 0.0004
712 URINARY TRACT INFECTION 49 0.0004
713 THIRST 5 0.0004
714 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0004
715 OEDEMA PERIPHERAL 42 0.0004
716 HYPERTENSION 63 0.0004
717 PULMONARY OEDEMA 14 0.0004
718 METASTASES TO LIVER 5 0.0004
719 ALOPECIA 61 0.0004
720 THERAPY CESSATION 14 0.0004
721 OSTEOMYELITIS 6 0.0004
722 RASH 121 0.0004
723 MUSCULOSKELETAL DISCOMFORT 5 0.0004
724 URINARY RETENTION 10 0.0004
725 SYNOVITIS 4 0.0004
726 ARTERIOSCLEROSIS 3 0.0004
727 INTERVERTEBRAL DISC PROTRUSION 7 0.0004
728 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0004
729 BLOOD POTASSIUM INCREASED 5 0.0004
730 ABDOMINAL DISCOMFORT 46 0.0004
731 BACTERIAL INFECTION 5 0.0004
732 LIVER FUNCTION TEST INCREASED 5 0.0004
733 ORAL HERPES 5 0.0004
734 MUSCLE SPASTICITY 4 0.0004
735 INFLUENZA 29 0.0004
736 CARPAL TUNNEL SYNDROME 4 0.0004
737 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0004
738 COGNITIVE DISORDER 13 0.0004
739 CELLULITIS 15 0.0004
740 EXPOSURE DURING PREGNANCY 16 0.0004
741 MALAISE 131 0.0004
742 PHARYNGEAL OEDEMA 6 0.0004
743 MANIA 5 0.0004
744 UPPER LIMB FRACTURE 6 0.0004
745 BODY TEMPERATURE INCREASED 6 0.0004
746 MENTAL DISORDER 12 0.0004
747 DERMATITIS CONTACT 3 0.0004
748 ECZEMA 7 0.0004
749 OSTEONECROSIS OF JAW 8 0.0004
750 DERMATITIS ATOPIC 3 0.0004
751 NAUSEA 217 0.0004
752 VOMITING 128 0.0004
753 TOOTHACHE 5 0.0004
754 LEUKOCYTOSIS 5 0.0004
755 MUCOSAL INFLAMMATION 7 0.0004
756 DIPLOPIA 7 0.0004
757 EMPHYSEMA 3 0.0004
758 BLOOD PRESSURE DECREASED 18 0.0004
759 EMOTIONAL DISTRESS 25 0.0004
760 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0004
761 NEUROTOXICITY 4 0.0004
762 CONSTIPATION 53 0.0004
763 BRONCHITIS 21 0.0004
764 EJECTION FRACTION DECREASED 4 0.0004
765 INSOMNIA 73 0.0004
766 DYSPNOEA EXERTIONAL 9 0.0004
767 CIRCULATORY COLLAPSE 5 0.0004
768 OSTEONECROSIS 10 0.0004
769 INTESTINAL OBSTRUCTION 9 0.0004
770 DIVERTICULITIS 7 0.0004
771 ROAD TRAFFIC ACCIDENT 11 0.0004
772 BLOOD TRIGLYCERIDES INCREASED 5 0.0004
773 INFLAMMATION 11 0.0004
774 PALPITATIONS 30 0.0004
775 PULMONARY ARTERIAL HYPERTENSION 4 0.0004
776 ANAPHYLACTIC SHOCK 6 0.0004
777 BLOOD COUNT ABNORMAL 6 0.0004
778 GAIT DISTURBANCE 49 0.0004
779 PRODUCT SUBSTITUTION ISSUE 15 0.0004
780 HYPOAESTHESIA 38 0.0004
781 BLOOD URINE PRESENT 5 0.0004
782 FEELING COLD 7 0.0003
783 CARDIAC ARREST 22 0.0003
784 PRURITUS 79 0.0003
785 ARTHRALGIA 92 0.0003
786 HAEMATOMA 7 0.0003
787 BLOOD PRESSURE INCREASED 37 0.0003
788 COMA 12 0.0003
789 GASTROINTESTINAL DISORDER 17 0.0003
790 DRUG INEFFECTIVE 301 0.0003
791 ATAXIA 3 0.0003
792 CHEST DISCOMFORT 23 0.0003
793 HEART RATE DECREASED 8 0.0003
794 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
795 SKIN EXFOLIATION 18 0.0003
796 RESPIRATORY DISORDER 7 0.0003
797 LETHARGY 14 0.0003
798 SKIN ULCER 6 0.0003
799 ORTHOSTATIC HYPOTENSION 4 0.0003
800 DISORIENTATION 10 0.0003
801 HYPOTENSION 45 0.0003
802 DRUG INTOLERANCE 19 0.0003
803 HYPERHIDROSIS 30 0.0003
804 STAPHYLOCOCCAL INFECTION 8 0.0003
805 PERIPHERAL SWELLING 30 0.0003
806 UPPER RESPIRATORY TRACT INFECTION 10 0.0003
807 PRODUCT USE ISSUE 37 0.0003
808 PULMONARY HYPERTENSION 5 0.0003
809 HEADACHE 138 0.0003
810 CHEST PAIN 43 0.0003
811 ADVERSE DRUG REACTION 16 0.0003
812 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0003
813 SKIN CANCER 4 0.0003
814 FLATULENCE 12 0.0003
815 DYSPNOEA 121 0.0003
816 SEIZURE 21 0.0003
817 CARDIAC DISORDER 21 0.0003
818 PANCREATIC CARCINOMA 6 0.0003
819 COUGH 54 0.0003
820 CARDIAC FAILURE CONGESTIVE 21 0.0003
821 HYPOGLYCAEMIA 11 0.0003
822 ACUTE MYOCARDIAL INFARCTION 7 0.0003
823 PAIN IN EXTREMITY 64 0.0003
824 PRESYNCOPE 5 0.0003
825 LOSS OF CONSCIOUSNESS 28 0.0003
826 HALLUCINATION, VISUAL 4 0.0003
827 CARDIOMEGALY 3 0.0003
828 DIZZINESS 103 0.0003
829 BLINDNESS 8 0.0003
830 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0003
831 TREMOR 36 0.0003
832 ANGIOEDEMA 9 0.0003
833 HEART RATE INCREASED 20 0.0003
834 VERTIGO 13 0.0003
835 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0003
836 MOUTH ULCERATION 4 0.0003
837 HEART RATE IRREGULAR 5 0.0003
838 PULMONARY EMBOLISM 21 0.0003
839 FALL 66 0.0003
840 DYSPEPSIA 19 0.0003
841 BRADYCARDIA 11 0.0003
842 POST PROCEDURAL COMPLICATION 4 0.0003
843 PALLOR 5 0.0003
844 SLEEP DISORDER 12 0.0003
845 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0003
846 DEPRESSION 48 0.0003
847 ARTHROPATHY 10 0.0003
848 EYE DISORDER 6 0.0003
849 PRODUCT DOSE OMISSION 18 0.0003
850 OXYGEN SATURATION DECREASED 9 0.0003
851 HAEMORRHAGE 19 0.0003
852 DISCOMFORT 9 0.0003
853 OROPHARYNGEAL PAIN 16 0.0003
854 URTICARIA 29 0.0003
855 PAIN 102 0.0003
856 NECK PAIN 10 0.0003
857 CYSTITIS 6 0.0003
858 TOXICITY TO VARIOUS AGENTS 28 0.0003
859 MOOD ALTERED 5 0.0003
860 CEREBROVASCULAR ACCIDENT 33 0.0002
861 ABASIA 6 0.0002
862 VISION BLURRED 23 0.0002
863 MYOCARDIAL INFARCTION 36 0.0002
864 LIMB DISCOMFORT 5 0.0002
865 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
866 DRY EYE 6 0.0002
867 NIGHT SWEATS 5 0.0002
868 LIMB INJURY 4 0.0002
869 ANOREXIA 3 0.0002
870 PROSTATE CANCER 12 0.0002
871 GASTRIC DISORDER 7 0.0002
872 BLOOD GLUCOSE ABNORMAL 3 0.0002
873 IMPAIRED HEALING 5 0.0002
874 SWELLING 14 0.0002
875 HEAD INJURY 5 0.0002
876 DISABILITY 3 0.0002
877 CHOKING 3 0.0002
878 ANXIETY 47 0.0002
879 DEEP VEIN THROMBOSIS 12 0.0002
880 PANIC ATTACK 6 0.0002
881 TACHYCARDIA 14 0.0002
882 SOMNOLENCE 32 0.0002
883 PRODUCT DOSE OMISSION ISSUE 13 0.0002
884 MUSCLE SPASMS 29 0.0002
885 PARAESTHESIA 25 0.0002
886 INTENTIONAL PRODUCT MISUSE 13 0.0002
887 RECTAL HAEMORRHAGE 7 0.0002
888 OESOPHAGEAL CARCINOMA 4 0.0002
889 UNRESPONSIVE TO STIMULI 4 0.0002
890 MOVEMENT DISORDER 5 0.0002
891 DRY MOUTH 12 0.0002
892 ABNORMAL BEHAVIOUR 7 0.0002
893 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0002
894 MOBILITY DECREASED 10 0.0002
895 FEELING HOT 9 0.0002
896 ARTHRITIS 11 0.0002
897 MEMORY IMPAIRMENT 20 0.0002
898 VISUAL ACUITY REDUCED 6 0.0002
899 THROMBOSIS 12 0.0002
900 SUICIDE ATTEMPT 9 0.0002
901 SYNCOPE 15 0.0002
902 AMNESIA 10 0.0002
903 MUSCULOSKELETAL PAIN 9 0.0002
904 NERVOUS SYSTEM DISORDER 5 0.0002
905 MEDICATION ERROR 8 0.0002
906 CONTUSION 13 0.0002
907 RASH GENERALISED 5 0.0002
908 SWELLING FACE 9 0.0002
909 HYPERSENSITIVITY 24 0.0002
910 BLOOD CHOLESTEROL INCREASED 6 0.0002
911 PRURITUS GENERALISED 4 0.0002
912 EAR INFECTION 3 0.0002
913 ACNE 11 0.0002
914 TINNITUS 6 0.0002
915 PSYCHOTIC DISORDER 4 0.0002
916 SPEECH DISORDER 7 0.0002
917 APHASIA 4 0.0002
918 CONFUSIONAL STATE 21 0.0002
919 DYSARTHRIA 5 0.0002
920 VISUAL IMPAIRMENT 14 0.0002
921 WEIGHT INCREASED 27 0.0002
922 EYE PAIN 6 0.0002
923 UNEVALUABLE EVENT 10 0.0002
924 ABNORMAL DREAMS 4 0.0002
925 DIABETIC KETOACIDOSIS 3 0.0002
926 ANAPHYLACTIC REACTION 6 0.0002
927 STRESS 8 0.0002
928 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0002
929 BREAST CANCER 12 0.0002
930 ASTHMA 11 0.0002
931 BLOOD GLUCOSE INCREASED 24 0.0002
932 DRY SKIN 14 0.0002
933 DRUG ADMINISTRATION ERROR 5 0.0002
934 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
935 NASOPHARYNGITIS 19 0.0002
936 HALLUCINATION 8 0.0002
937 SINUSITIS 11 0.0002
938 CONVULSION 9 0.0002
939 JOINT SWELLING 12 0.0002
940 BURNING SENSATION 8 0.0002
941 DRUG PRESCRIBING ERROR 3 0.0002
942 ERYTHEMA 23 0.0002
943 UNDERDOSE 8 0.0002
944 EYE SWELLING 4 0.0002
945 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0002
946 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
947 SKIN DISCOLOURATION 5 0.0002
948 TRANSIENT ISCHAEMIC ATTACK 4 0.0002
949 DYSPHONIA 6 0.0002
950 NIGHTMARE 4 0.0002
951 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
952 SUICIDAL IDEATION 10 0.0001
953 VAGINAL HAEMORRHAGE 5 0.0001
954 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
955 DYSSTASIA 3 0.0001
956 DRUG ABUSE 8 0.0001
957 OVERDOSE 20 0.0001
958 NASAL CONGESTION 5 0.0001
959 OSTEOARTHRITIS 4 0.0001
960 FLUSHING 11 0.0001
961 CARDIOVASCULAR DISORDER 3 0.0001
962 PRODUCTIVE COUGH 4 0.0001
963 WHEEZING 5 0.0001
964 FLUID RETENTION 5 0.0001
965 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
966 HOT FLUSH 6 0.0001
967 BALANCE DISORDER 8 0.0001
968 AGITATION 7 0.0001
969 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
970 CORONARY ARTERY DISEASE 3 0.0001
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
973 ANGER 3 0.0001
974 DEPRESSED MOOD 4 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
976 INFLUENZA LIKE ILLNESS 7 0.0001
977 PRODUCT QUALITY ISSUE 12 0.0001
978 DRUG HYPERSENSITIVITY 15 0.0001
979 PSORIASIS 9 0.0001
980 DYSKINESIA 3 0.0001
981 RHINORRHOEA 4 0.0001
982 MIGRAINE 6 0.0001
983 RHEUMATOID ARTHRITIS 7 0.0001
984 NERVOUSNESS 4 0.0001
985 DYSGEUSIA 5 0.0001
986 DRUG EFFECT DECREASED 5 0.0001
987 COLORECTAL CANCER 3 0.0001
988 DRUG EFFECT INCOMPLETE 3 0.0001
989 DEVICE MALFUNCTION 3 0.0001
990 INCORRECT DOSE ADMINISTERED 9 0.0001
991 FEELING ABNORMAL 14 0.0001
992 AGGRESSION 3 0.0001
993 DISTURBANCE IN ATTENTION 3 0.0001
994 BLADDER CANCER 3 0.0001
995 MUSCULOSKELETAL STIFFNESS 4 0.0001
996 COMPLETED SUICIDE 4 0.0001
997 INJECTION SITE ERYTHEMA 4 0.0000